How COVID-19-related stressors altered drunkenness frequency.
New trial shows felzartamab reduces proteinuria in IgA nephropathy patients
IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface.